The results of Western blotting showed that HK2 protein expression was not affected by NaBu in the c‐myc siRNA knockdown HCC cells, which demonstrated that c‐myc was the target of NaBu when inhibiting HK2 in the HCC cells (Figure 4L). The gene discussed is MYC; the disease is hepatocellular carcinoma.